Riding the pepTIDE — The Daily Wire on Therapeutic Peptides

An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.

Topic Sections

  • Top Shots — The most significant peptide and longevity stories ranked by overall editorial score
  • Research Signals — High-credibility scientific findings from journals, preprints, and clinical sources
  • Healing & Recovery — Tissue repair, injury recovery, and gut healing peptides including BPC-157 and TB-500
  • Growth Hormone Wire — Growth hormone secretagogues, peptide stacks, and GH axis research including Ipamorelin, CJC-1295, and MK-677
  • Metabolic & GLP-1 — Metabolic health, insulin sensitivity, and GLP-1 receptor agonist research including semaglutide and tirzepatide
  • Cognitive / Nootropic — Peptides targeting brain function, memory, neuroprotection, and cognitive enhancement
  • Skin & Cosmetic — Skin repair, anti-aging, collagen synthesis, and cosmetic peptide research including GHK-Cu and matrixyl
  • Reddit Finds — Community-sourced discussions, self-experimentation reports, and protocol threads from peptide communities
  • Contrarian Takes — Alternative viewpoints, dissenting research, and perspectives that challenge mainstream peptide narratives
  • Skeptic's Corner — Hype debunking, low-evidence alerts, and critical analysis of overstated peptide claims

Browse by Filter

  • Newest — Latest peptide and longevity stories
  • Most Credible — Highest credibility-scored stories
  • Most Edgy — High-novelty, unconventional findings
  • Most Discussed — Trending community discussions
  • Most Actionable — Direct applicability to daily health protocols
  • Lowest Risk — Stories with strong evidence, low hype
  • Research Only — Peer-reviewed and preprint studies
  • Reddit Only — Community discussion and anecdote
  • GLP-1 / Metabolic — Semaglutide, tirzepatide, and metabolic peptides
  • Healing / Recovery — BPC-157, TB-500, and repair protocols

More

  • About Riding the pepTIDE
  • Health Disclaimer
  • Submit a Source
  • Contact

Wegovy at 60: Less Belly Fat, Possible Muscle Loss

A person in their 60s who started Wegovy (semaglutide) asked whether they can lose belly fat without losing muscle. They mentioned using protein supplements and working with a trainer, and wanted to know what to expect. This is a common and reasonable worry because weight loss can include both fat and muscle. Semaglutide is the active drug in Wegovy and Ozempic. It’s a man-made version of a natural hormone that helps control appetite and digestion. In plain terms, it makes many people feel less hungry, so they eat less and often lose weight. It doesn’t directly “burn” fat or build muscle like exercise does — it mainly helps reduce calorie intake. What the evidence so far shows is that people on semaglutide usually lose a lot of fat, including belly (visceral) fat, but they also tend to lose some lean mass (muscle and water). Most clinical studies are in adults, and they measure groups of people over months to a couple of years. On average, the majority of weight lost is fat, but 10–30% of the total weight loss can be lean mass in some reports. The exact amount varies with diet, exercise, age, and starting muscle. Older adults are more prone to losing muscle during weight loss, so your concern is justified. The practical takeaway: what you’re already doing — enough protein and resistance (strength) training — is the right strategy to help preserve muscle while losing fat. Aim for regular strength workouts, prioritize protein spread across meals, and work with your trainer to focus on progressive resistance rather than just cardio. Your body is likely to reduce belly fat on Wegovy, but without targeted effort you may still lose some muscle. Tracking strength (how your lifts feel) and simple function (walking, stairs) is often a better real-world gauge than the scale alone. Caveats and risks: individual responses vary. Studies report averages, not guarantees. Semaglutide has side effects like nausea, constipation, or diarrhea for some people, which can affect appetite and nutrient intake. Rapid or very large weight loss raises the risk of muscle loss, especially in older adults. If you have certain medical conditions or are taking other medications, check with your doctor. Wegovy is a prescription drug and should be used under medical supervision. Your care team can help adjust dosing, nutrition, and exercise plans to minimize muscle loss. Bottom line: semaglutide can help reduce belly fat, and with enough protein and focused strength training you can greatly reduce the chance of losing muscle — but expect to watch and adjust things with your doctor and trainer as you go.

Source: r/Semaglutide

Read full story

Back to Riding the pepTIDE